Literature DB >> 16101597

The prevention of cervical cancer in developing countries.

Lynette Denny1.   

Abstract

Cervical cancer remains the commonest cancer cause of death among women in developing countries, largely due to the failure to establish cytologically based cervical cancer screening programmes. There are many barriers to the establishment of screening programmes in poor countries ranging from limited financial, human and health resources to the complex infrastructural requirements of traditional screening programmes. Alternative approaches to cervical cancer prevention are currently being investigated, including primary prevention with prophylactic vaccines against human papillomavirus to alternative screening tests and protocols. These will be explored in this review.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101597     DOI: 10.1111/j.1471-0528.2005.00713.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  16 in total

1.  Maternal support for human papillomavirus vaccination in Honduras.

Authors:  Rebecca B Perkins; Sarah M Langrish; Deborah J Cotton; Carol J Simon
Journal:  J Womens Health (Larchmt)       Date:  2010-11-22       Impact factor: 2.681

2.  Awareness, acceptability and uptake of human papilloma virus vaccine among Cameroonian school-attending female adolescents.

Authors:  Claudine Akono Ayissi; Richard G Wamai; Geofrey O Oduwo; Stacey Perlman; Edith Welty; Thomas Welty; Simon Manga; Javier Gordon Ogembo
Journal:  J Community Health       Date:  2012-12

3.  Ensuring access to HPV vaccines through integrated services: a reproductive health perspective.

Authors:  Amy E Pollack; Miranda Balkin; Lindsay Edouard; Felicity Cutts; Nathalie Broutet
Journal:  Bull World Health Organ       Date:  2007-01       Impact factor: 9.408

4.  High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.

Authors:  Deepa Reddy; Joseph Njala; Penny Stocker; Alan Schooley; Martiniano Flores; Chi-Hong Tseng; Colin Pfaff; Perry Jansen; Ronald T Mitsuyasu; Risa M Hoffman
Journal:  Int J STD AIDS       Date:  2014-06-13       Impact factor: 1.359

5.  Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.

Authors:  Rebecca B Perkins; Sarah M Langrish; Linda J Stern; James F Burgess; Carol J Simon
Journal:  Womens Health Issues       Date:  2009-11-26

6.  Exploring barriers to the delivery of cervical cancer screening and early treatment services in Malawi: some views from service providers.

Authors:  Alister C Munthali; Bagrey M Ngwira; Frank Taulo
Journal:  Patient Prefer Adherence       Date:  2015-03-24       Impact factor: 2.711

Review 7.  Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.

Authors:  Margaret M Demment; Karen Peters; J Andrew Dykens; Ann Dozier; Haq Nawaz; Scott McIntosh; Jennifer S Smith; Angela Sy; Tracy Irwin; Thomas T Fogg; Mahmooda Khaliq; Rachel Blumenfeld; Mehran Massoudi; Timothy De Ver Dye
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

8.  Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.

Authors:  Seung Won Byun; Ahwon Lee; Suyeon Kim; Yeong Jin Choi; Youn Soo Lee; Jong Sup Park
Journal:  Int J Med Sci       Date:  2013-09-12       Impact factor: 3.738

9.  Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities.

Authors:  Emmanuela Gakidou; Stella Nordhagen; Ziad Obermeyer
Journal:  PLoS Med       Date:  2008-06-17       Impact factor: 11.069

10.  A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in southeast Nigeria.

Authors:  Justus N Eze; Esther N Emeka-Irem; Felix O Edegbe
Journal:  Clin Med Insights Oncol       Date:  2013-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.